Response to Comments: MolDX - CDD: Oncotype DX ® Breast Cancer for DCIS (Genomic Health ™)

This record is an administrative notice stating that CGS Administrators received no public comments during the open comment period (2016-11-16 to 2017-01-03) on draft policy DL36951, MolDX - CDD: Oncotype DX Breast Cancer for DCIS. The document does not contain clinical coverage criteria, limitations, or documentation requirements; consult draft policy DL36951 for the substantive coverage policy details.